BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24718826)

  • 21. [Guillain-Barré syndrome].
    Ohkoshi N
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():634-9. PubMed ID: 23156588
    [No Abstract]   [Full Text] [Related]  

  • 22. [Development of a severe multiphase disseminated encephalomyelitis in Guillain-Barre syndrome--MRI findings].
    Korn A; Huberle E; Bornemann A
    Rofo; 2010 Jun; 182(6):525-7. PubMed ID: 20419614
    [No Abstract]   [Full Text] [Related]  

  • 23. The many faces of demyelinating diseases: acute disseminated encephalomyelitis and Guillain-Barré syndrome in the same patient.
    Trindade RAR; Klaes AINM; Duarte JÁ
    Arq Neuropsiquiatr; 2017 May; 75(5):324-325. PubMed ID: 28591395
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
    Isai A; Durand J; Le Meur S; Hidalgo-Simon A; Kurz X
    Vaccine; 2012 Nov; 30(49):7123-9. PubMed ID: 23022149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
    Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
    Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rehabilitation outcomes after combined acute disseminated encephalomyelitis and Guillain-Barré syndrome in a child: a case report.
    Korupolu R; Ngo T; Hack N; Escott E; Salles S
    J Pediatr Rehabil Med; 2014; 7(3):267-72. PubMed ID: 25260509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
    Choe YJ; Cho H; Bae GR; Lee JK
    Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barre syndrome after influenza vaccine administration: two adult cases.
    Bedard Marrero V; Osorio Figueroa RL; Vázquez Torres O
    Bol Asoc Med P R; 2010; 102(2):39-41. PubMed ID: 20939203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination-associated acute-onset chronic inflammatory demyelinating polyneuropathy followed by acute disseminated encephalomyelitis in a postpartum woman.
    Kim W; An JY
    Acta Neurol Belg; 2021 Jun; 121(3):771-774. PubMed ID: 32808243
    [No Abstract]   [Full Text] [Related]  

  • 31. Co-morbid Guillain-Barré syndrome and acute disseminated encephalomyelitis.
    Mohammed RR; Jan MM
    Neurosciences (Riyadh); 2013 Apr; 18(2):166-8. PubMed ID: 23545617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination.
    Denholm JT; Neal A; Yan B; Petty S; Knox J; French C; Marshall C
    Neurology; 2010 Dec; 75(24):2246-8. PubMed ID: 21172848
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccination-associated acute disseminated encephalomyelitis.
    Torisu H; Okada K
    Vaccine; 2019 Feb; 37(8):1126-1129. PubMed ID: 30683508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
    Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: "Chart-confirmed Guillain-Barré syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010".
    Stang A
    Am J Epidemiol; 2014 Mar; 179(5):660. PubMed ID: 24550085
    [No Abstract]   [Full Text] [Related]  

  • 36. Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.
    Nasreen S; Calzavara A; Buchan SA; Thampi N; Johnson C; Wilson SE; Kwong JC;
    Vaccine; 2022 May; 40(24):3305-3312. PubMed ID: 35527057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute disseminated encephalomyelitis secondary to influenza vaccination].
    Garea García-Malvar MJ; Moche Loeri JA; Bachiller Luque P; Fernández Gómez C
    An Med Interna; 2004 Sep; 21(9):462-3. PubMed ID: 15476427
    [No Abstract]   [Full Text] [Related]  

  • 38. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
    Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
    Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Limbic encephalitis caused by herpes simplex virus infection after vaccination against the influenza virus].
    Utumi Y; Iseki E; Murayama N; Ichimiya Y; Arai H
    Brain Nerve; 2010 Jun; 62(6):615-9. PubMed ID: 20548122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome.
    Ling L; Bagshaw SM; Villeneuve PM
    CMAJ; 2021 Nov; 193(46):E1766-E1769. PubMed ID: 34810163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.